Arifine-MT 2.5 Tablet belongs to a class of drugs called antipsychotics and mood stabilizers primarily used to treat mood disorders like schizophrenia, irritability linked with autism, and Tourette's syndrome. Besides this, Arifine-MT 2.5 Tablet also helps in managing mental depression along with other antidepressant medicines. Schizophrenia affects the ability of a person to feel, think and behave clearly. Tourette's syndrome is a mental disorder characterized by uncontrollable, repetitive movements or unwanted sounds (tics). Psychosis may be caused due to disturbances in chemical messenger activity known as neurotransmitters (like dopamine and serotonin) in the brain.

Arifine-MT 2.5 Tablet contains Aripiprazole which stabilizes and blocks the dopamine and serotonin receptors in the brain, preventing its overactivity, thereby controlling the positive symptoms like hallucinations, misbelief, and unfriendly characteristics of schizophrenia. Arifine-MT 2.5 Tablet improves the activity of dopamine and serotonin receptors in other areas of the brain. It helps control negative symptoms (like lack of emotion, social isolation, poor attention, and memory loss) of schizophrenia. Thus, Arifine-MT 2.5 Tablet improves mood swings, depression, and other psychotic problems. 

Take Arifine-MT 2.5 Tablet as prescribed. Your doctor will advise you how often you take Arifine-MT 2.5 Tablet based on your medical condition. Some people may experience drowsiness, headache, tiredness, akathisia (inability to sit still), difficulty sleeping, light-headedness, indigestion, shaking, blurred vision, nausea, vomiting, anxiety, and increased saliva production. Most of these side effects of Arifine-MT 2.5 Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Arifine-MT 2.5 Tablet or any other medicines, please tell your doctor. Arifine-MT 2.5 Tablet should be used with caution in elderly patients above 65 years of age. There is an increased risk of adverse reactions such as dizziness, inability to move and balance, orthostatic hypotension (fall in blood pressure when standing up), and drowsiness. Avoid taking Arifine-MT 2.5 Tablet if you are pregnant or breastfeeding and consult a doctor. Arifine-MT 2.5 Tablet is not recommended for children below 15 years of age. If you have any self-harming thoughts or behavior while taking Arifine-MT 2.5 Tablet , please contact a doctor immediately. If you have diabetes, abnormal blood pressure, high cholesterol, fits, involuntary muscle movements especially in the face, attention-deficit hyperactivity disorder (ADHD), blood clots, a history of stroke or heart attack, kidney or liver problems, inform your doctor before taking Arifine-MT 2.5 Tablet . 

Arifine-MT 2.5 Tablet contains Aripiprazole which helps treat various psychotic conditions like schizophrenia, mood disorders (such as mania and bipolar disorder), and sometimes depression. Arifine-MT 2.5 Tablet inhibits the dopamine receptor in our brain thereby controlling the positive symptoms (like hallucinations, misbelief, and unfriendliness) and negative symptoms (like social isolation, lack of emotion, poor attention, and memory loss) of schizophrenia. Thus, Arifine-MT 2.5 Tablet improves overall behavior and thoughts and helps in having a better social life and comfortably doing daily activities. Arifine-MT 2.5 Tablet may be used in combination with other medicines to treat depression. Additionally, Arifine-MT 2.5 Tablet is also used to reduce unwanted sounds (tics) severity in Tourette's syndrome (a nervous system problem that causes unwanted sounds or sudden movements). 

If you are allergic to Arifine-MT 2.5 Tablet or any other medicines, please tell your doctor. Arifine-MT 2.5 Tablet should be used with caution in elderly patients above 65 years of age as there is an increased risk of adverse reactions such as dizziness, changes in the ability to move and balance, orthostatic hypotension (fall in blood pressure when standing up), and drowsiness. Avoid taking Arifine-MT 2.5 Tablet if you are pregnant or breastfeeding and consult a doctor. Arifine-MT 2.5 Tablet is not recommended for children below 15 years of age. If you have any self-harming thoughts or behavior while taking Arifine-MT 2.5 Tablet , please contact a doctor immediately. If you develop impulse control disorders such as excessive eating, spending, addictive gambling, or abnormally high sex drive, inform your doctor so that the dose may be adjusted appropriately, or are advised to stop taking Arifine-MT 2.5 Tablet . If you have diabetes, abnormal blood pressure, high cholesterol, fits, involuntary muscle movements especially in the face, attention-deficit hyperactivity disorder (ADHD), blood clots, history of stroke or heart attack, kidney or liver problems, inform your doctor before taking Arifine-MT 2.5 Tablet .

• Elderly patients more than 65 years with dementia-related psychosis treated with Arifine-MT 2.5 Tablet can be at an increased risk of death. 
• Arifine-MT 2.5 Tablet is not prescribed and approved for the treatment of dementia-related psychosis. 
• Increased risk of suicidal thinking and behavior changes has been observed in children, adolescents, and young adults taking Arifine-MT 2.5 Tablet , so close monitoring for worsening and the emergence of suicidal thoughts and behaviours is required.